4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-22-026898
EVP, Corp Strategy & Develop sold 6,409 shares at an average $224.25 ($1,437,205)
- EVP, Corp Strategy & Develop acquired 6,409 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2022-12-01 | Option exercise | +6,409 | $109.34 | $700,760 | 26,641 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2022-12-01 | Sale | −1,138 | $223.06 | $253,837 | 25,503 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2022-12-01 | Sale | −4,165 | $224.41 | $934,684 | 21,338 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2022-12-01 | Sale | −1,106 | $224.85 | $248,684 | 20,232 | D |
| Derivatives | |||||||
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2022-12-01 | Option exercise · Stock Options (Right to Buy) | −6,409 | 0 | D | ||
| Open-market sales · 6,409 sh · avg $224.25 · $1,437,205 | |||||||
Loading xslF345X03/form4.xml…